Jie Wu
0000-0002-5737-8608
Publication & Citation Trends
Publications
0 total
The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinases. OA
Cited by 9
Semantic Scholar
Abstract 3851: Targeting RET solvent-front mutants with an alkynyl nicotinamide-based inhibitor
Cited by 0
Semantic Scholar
Progress and challenges in RET-targeted cancer therapy
Cited by 14
Semantic Scholar
Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors. OA
Cited by 7
Semantic Scholar
Novel TBP-RET (TATA.binding protein-rearranged during transfection) fusion in a rare case of Skene gland adenocarcinoma: Sequencing unicorns OA
Cited by 0
Semantic Scholar
Precision therapy for RET-altered cancers with RET inhibitors OA
Cited by 123
Semantic Scholar
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib OA
Cited by 41
Semantic Scholar
mRNA expression profile analysis reveals a C-MYC/miR-34a pathway involved in the apoptosis of diffuse large B-cell lymphoma cells induced by Yiqichutan treatment OA
Cited by 6
Semantic Scholar
RET kinase alterations in targeted cancer therapy OA
Cited by 20
Semantic Scholar
Research Topics
Rabies epidemiology and control
(10)
Microbial infections and disease research
(6)
Poxvirus research and outbreaks
(5)
Genomics and Phylogenetic Studies
(3)
Plant and animal studies
(3)
Affiliations
Jiangsu Normal University
Nanjing Agricultural University
Shanghai Jiao Tong University
Yunnan Agricultural University
Millennium Institute